IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 324.97M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $324.97M | (m) | (m) |
| 2026-03-31 | (m) | $285.61M | (m) | (m) |
| 2025-12-31 | (m) | $263.50M | (m) | (m) |
| 2025-09-30 | (m) | $250.43M | (m) | (m) |
| 2025-06-30 | (m) | $241.53M | (m) | (m) |
| 2025-03-31 | (m) | $212.68M | (m) | (m) |
| 2024-12-31 | (m) | $164.07M | (m) | (m) |
| 2024-09-30 | (m) | $90.86M | (m) | (m) |
| 2024-06-30 | (m) | $32.77M | (m) | (m) |
| 2024-03-31 | (m) | $1.90M | (m) | (m) |
| 2023-12-31 | (m) | $1.19M | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $0.00 | (m) | (m) |
| 2018-12-31 | (m) | $0.00 | (m) | (m) |
| 2018-09-30 | (m) | $0.00 | (m) | (m) |
| 2018-06-30 | (m) | $0.00 | (m) | (m) |
| 2018-03-31 | (m) | $0.00 | (m) | (m) |
| 2017-12-31 | (m) | $0.00 | (m) | (m) |
| 2017-09-30 | (m) | $0.00 | (m) | (m) |
| 2017-06-30 | (m) | $0.00 | (m) | (m) |
| 2017-03-31 | (m) | $0.00 | (m) | (m) |
| 2016-12-31 | (m) | $0.00 | (m) | (m) |
| 2016-09-30 | (m) | $0.00 | (m) | (m) |
| 2016-06-30 | (m) | $0.00 | (m) | (m) |
| 2016-03-31 | (m) | $0.00 | (m) | (m) |
| 2015-12-31 | (m) | $0.00 | (m) | (m) |
| 2015-09-30 | (m) | $0.00 | (m) | (m) |
| 2015-06-30 | (m) | $0.00 | (m) | (m) |
| 2015-03-31 | (m) | $0.00 | (m) | (m) |
| 2014-12-31 | (m) | $0.00 | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |